drugset / Trial / NCT05952102
Nigella Sativa as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia
RandomizedParallel-groupDouble-blindTreatment
Summary
Nigella sativa is the world's oldest immunomodulator. The main active component in Nigella sativa is thymoquinone. Research shows thymoquinone has antioxidant, anti-inflammatory, and antimicrobial effects. Based on these observations on the pharmacological activities of Nigella sativa, the potential therapeutic efficacy of N. Sativa was proposed in CAP.
Timeline
- Start
- 2023-08-01
- Primary completion
- 2024-05
- Completion
- 2024-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nigella Sativa Oil | Traditional medicine (herbal / TCM) | 40 mg/kg | Oral |
Indications
No indication recorded.